Homology Medicines, Inc. (FIXX) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE PATRIOTS PARK
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments127,071150,025175,026201,074225,523256,126
Cash and cash equivalents76,79739,45433,98643,162176,188248,127
Short-term investments50,274110,571141,040157,91249,3357,999
Other undisclosed current assets4,2653,5585,98912,13012,9176,322
Total current assets:131,336153,583181,015213,204238,440262,448
Noncurrent Assets
Operating lease, right-of-use asset19,83720,20020,56320,90015,15115,609
Property, plant and equipment 8451,0621,0781,4151,7201,986
Long-term investments and receivables17,31923,03625,80027,100 30,600
Long-term investments17,31923,03625,80027,100 30,600
Other undisclosed noncurrent assets   143229,298315
Total noncurrent assets:38,00144,29847,45549,44746,16948,510
TOTAL ASSETS:169,337197,881228,470262,651284,609310,958
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,6367,32510,41214,2538,20513,497
Employee-related liabilities4,0483,7092,406
Accounts payable3,3933,6351,1444,8353,7629,885
Accrued liabilities5,2433,6909,2685,3707341,206
Deferred revenue  3541,1561,9582,7603,208
Deferred compensation liability 800800800  800
Other undisclosed current liabilities13,50310,02810,2089,0419,7693,297
Total current liabilities:22,93918,50722,57625,25220,73420,802
Noncurrent Liabilities
Long-term debt and lease obligation:    28,33823,58723,548
Liabilities, other than long-term debt27,02327,47527,916  354
Deferred revenue      354
Operating lease, liability27,02327,47527,91628,33823,58723,548
Other undisclosed noncurrent liabilities    (28,338)(23,587) 
Total noncurrent liabilities:27,02327,47527,91628,33823,58723,902
Total liabilities:49,96245,98250,49253,59044,32144,704
Equity
Equity, attributable to parent119,375151,899177,978209,061240,288266,254
Common stock666666
Additional paid in capital612,482610,056607,513604,354601,439598,275
Accumulated other comprehensive loss(88)(182)(404)(457)(41) 
Accumulated deficit(493,025)(457,981)(429,137)(394,842)(361,116)(332,027)
Total equity:119,375151,899177,978209,061240,288266,254
TOTAL LIABILITIES AND EQUITY:169,337197,881228,470262,651284,609310,958

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues 354802802802802802
Amortization of lease incentives6,320
Sublease income  769769  310
Gross profit: 354802802802802802
Operating expenses(31,170)(28,313)(35,296)(33,664)(29,109)(38,420)
Operating loss:(30,816)(27,511)(34,494)(32,862)(28,307)(37,618)
Nonoperating income
(Other Nonoperating income)
1,5111,4691,4551,269474131,281
Income (loss) from continuing operations before income taxes:(29,305)(26,042)(33,039)(31,593)(27,833)93,663
Income tax benefit   10146105967
Income (loss) from continuing operations:(29,305)(26,042)(32,938)(31,547)(27,728)94,630
Income (loss) before gain (loss) on sale of properties:(31,547)(27,728)94,630
Other undisclosed net loss  (2,802)(1,357)  (2,525)
Net income (loss):(29,305)(28,844)(34,295)(31,547)(27,728)92,105
Other undisclosed net loss attributable to parent(5,739)  (2,179)(1,361) 
Net income (loss) available to common stockholders, basic:(35,044)(28,844)(34,295)(33,726)(29,089)92,105
Dilutive securities, effect on basic earnings per share      595,613
Other undisclosed net loss available to common stockholders, diluted   (528,899)   
Net income (loss) available to common stockholders, diluted:(35,044)(28,844)(563,194)(33,726)(29,089)687,718

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(29,305)(28,844)(34,295)(31,547)(27,728)92,105
Comprehensive income (loss):(29,305)(28,844)(34,295)(31,547)(27,728)92,105
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(5,645)22253(2,595)(1,402)7
Comprehensive income (loss), net of tax, attributable to parent:(34,950)(28,622)(34,242)(34,142)(29,130)92,112

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: